Tempest Therapeutics, Inc. Other Non-Current Assets
Tempest Therapeutics, Inc. (TPST) had Other Non-Current Assets of $501.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Noncurrent $501.00K.
- 2026-03-31: Other Assets, Noncurrent $509.00K.
- 2025-12-31: Other Assets, Noncurrent $517.00K.
- 2025-09-30: Other Assets, Noncurrent $519.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $501.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $509.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $517.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $519.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $529.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $538.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $485.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $448.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $448.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $448.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $448.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $393.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $398.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $429.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $429.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $683.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $480.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $480.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $111.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $112.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $112.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $111.00K 10-Q · filed 2022-05-13 | $299.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $51.00K 10-K · filed 2022-03-29 | $351.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $51.00K 10-Q · filed 2021-11-10 | $389.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $444.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $555.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $507.00K 10-K · filed 2021-03-29 | |
| 2019-09-30 | $765.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $805.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $333.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $213.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $24.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $24.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $74.00K 10-K · filed 2019-04-01 | $24.00K 10-K · filed 2018-03-15 |
| 2017-09-30 | $23.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $23.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $23.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $23.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $23.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $23.00K 10-Q · filed 2016-08-04 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-02 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 | |
| 2014-12-31 | $130.00K 10-K · filed 2016-02-26 | |
| 2013-09-30 | $88.00K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $88.00K 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $88.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $93.00K 10-Q · filed 2013-11-13 | |
| 2012-09-30 | $93.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $275.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |